Treatment of Epilepsy With Diphenylhydantoin Sodium

REFERENCES

• Merritt, H. H. and Putnam, T. J.: A new series of anticonvulsant drugs tested by experiments on animals. Arch. Neurol. & Psychiat. 39: 1003–1015, 1938.
   Google Scholar
• Merritt, H. H. and Putnam, T. J.: Sodium diphenyl hydantoinate in the treatment of convulsive disorders. J.A.M.A. 111: 1068, 1938.
   Google Scholar
• Walker, C. F. and Kirkpatrick, B. B.: Dilantin (diphenylhydantoin) treatment for behavior problem children with abnormal electroencephalograms. Am. J. Psychiat. 103: 484–492 (January) 1947.
   PubMed Web of Science ®Google Scholar
• Pasamanick, B.: Anticonvulsant drug therapy of behavior problem children with abnormal electroencephalograms. Arch. Neurol. & Psychiat. 65: 752–766 (June) 1951.
   Google Scholar
• Putnam, T. J. and Rothenberg, S. F.: Results of intensive (narcosis) and standard medical treatment of epilepsy. J.A.M.A. 152: 1400–1406, 1953.
   PubMed Web of Science ®Google Scholar
• Murphy, J. T. and Schwab, R. S.: Diphenylhydantoin (Dilantin) sodium used parenterally in control of convulsions. J.A.M.A. 160: 385–388 (February 4) 1956.
   PubMed Web of Science ®Google Scholar
• Illingworth, R. S.: Abnormal substances excreted in human milk. Practitioner 171: 533–538, 1953.
   PubMedGoogle Scholar
• Robinson, L. J.: Case of acute poisoning from Dilantin sodium with recovery. J.A.M.A. 115: 289, 1940.
   Google Scholar
• Nauth-Misir, T. N.: A case of gross overdose of soluble phenytoin. Brit. M. J. 2: 646, 1948.
   PubMedGoogle Scholar
• Aring, C. D. and Rosbnbaum, M.: Ingestion of large doses of Dilantin sodium. Arch. Neurol. & Psychiat. 45: 265, 1941.
   Google Scholar
• Price, W. C. and Frank, M. E.: Accidental acute Dilantin poisoning: Report of a case with complete recovery in a non-epileptic child. J. Pediat. 36: 652–655, 1950.
   PubMed Web of Science ®Google Scholar
• Young, A. W.: A case of poisoning with Dilantin (sodium diphenyl hydantoinate). M. J. Australia 1: 68–69, 1949.
   Google Scholar
• Cattan, R., Frumusan, P. and Attal, C.: Acute intoxication with Dilantin. Bull, et mém. Soc. méd. d. hôp. de Paris 63: 346, 1947.
   PubMedGoogle Scholar
• Tichner, J. B. and Enselberg, C. D.: Suicidal Dilantin (sodium diphenylhydantoin) poisoning: A case report. New England J. Med. 245: 723 (November 8) 1951.
   PubMed Web of Science ®Google Scholar
• Levitt, J. M. and Blonstein, M.: Toxic amblyopia resulting from sodium diphenyl hydantoinate. New York State J. Med. 40: 1538, 1940.
   Google Scholar
• Reichelderfer, T. E., Pearson, P. H. and Livingston, S.: Thrombocytopenia purpura occurring in association with Paradione (paramethadione) and Dilantin sodium (phenytoin sodium) therapy. J. Pediat. 43: 42–46, 1952.
   Google Scholar
• Van Wyk, J. J. and Hoffman, C. R.: Periarteritis nodosa: A case of fatal exfoliative dermatitis resulting from Dilantin sodium sensitization. Arch. Int. Med. 81: 605, 1948.
   Google Scholar
• Heller, C. and Sloan, M.: Erythema bullosum malignans following Dilantin therapy. Pediatrics 5: 836–839, 1950.
   PubMed Web of Science ®Google Scholar
• Ellis, F. A.: Reactions to Nirvanol, phenytoin sodium and phenobarbital. Report of a case of ectodermosis erosiva pluriorificialis following the ingestion of phenytoin sodium. South. M. J. 36: 575, 1943.
   Google Scholar
• Ritchie, E. B. and Kolb, W.: Reaction to sodium diphenyl hydantoinate (Dilantin sodium). Arch. Dermat. & Syph. 46: 856, 1942.
   Google Scholar
• Mandelbaum, Harry and Kane, L. J.: Dilantin sodium poisoning. Arch. Neurol. & Psychiat. 45: 769 (May) 1941.
   Google Scholar
• Chaikbn, B. H., Goldbkrc, R. I. and Segal, J. P.: Dilantin sensitivity. Report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. New England J. Med. 242: 897–898 (June 8) 1950.
   Google Scholar
• Gropper, A. L.: Diphenylhydantoin sensitivity. Report of fatal case with hepatitis and exfoliative dermatitis. New England J. Med. 254: 522–523, 1956.
   PubMed Web of Science ®Google Scholar
• Kimball, O. P.: The treatment of epilepsy with sodium diphenyl hydantoinate. J.A.M.A. 112: 1244 (April 1) 1939.
   Google Scholar
• Esterberg, H. L. and White, P. H.: Sodium Dilantin gingival hyperplasia. J. Am. Dent. A. 32: 16–24, 1945.
   Web of Science ®Google Scholar
• Crome, L.: The histological changes in hydantoinate gingivitis. J. Clin. Path. 5: 244–245, 1954.
   Web of Science ®Google Scholar
• Wilkins, Lawson: The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence. Springfield, Illinois, Charles C. Thomas, 1950.
   Google Scholar
• Finkelman, I. and Arieff, A. J.: Untoward effects of phenytoin sodium in epilepsy. J.A.M.A. 118: 1209, 1942.
   Google Scholar
• Williamson, B. A. M.: Severe toxic effects of sodium diphenyl hydantoinate in mentally defective epileptics. J. Ment. Sc. 86: 981, 1940.
   Google Scholar
• Dickerson, W. W.: The present status of Dilantin therapy. Am. J. Psychiat. 98: 515–523, 1942.
   Google Scholar
• Schoemperlen, C. B.: Agranulocytosis due to Dilantin sodium. Manitoba M. A. Rev. 27: 687–688 (December) 1947.
   PubMedGoogle Scholar
• Rhind, E. G. and Varadi, S.: Megaloblastic anaemia due to phenytoin sodium. Lancet 2: 921, 1953.
   Web of Science ®Google Scholar
• Webster, J. M.: Megaloblastic anaemia due to phenytoin sodium. Lancet 2: 1017, 1954.
   Web of Science ®Google Scholar
• Chalmers, J. M. and Boheimer, K.: Megaloblastic anaemia and anticonvulsant therapy. Lancet 2: 920, 1954.
   Web of Science ®Google Scholar
• Hawkins, C. F. and Meynell, M. J.: Megaloblastic anaemia due to phenytoin sodium. Lancet 2: 737, 1954.
   Web of Science ®Google Scholar
• Berlyne, N. and Levene, M.: Megaloblastic anaemia following anticonvulsants. Brit. M. J. 1: 1247, 1955.
   PubMedGoogle Scholar
• Ryan, G. M. S. and Forshaw, J. W. B.: Megaloblastic anaemia due to phenytoin sodium. Brit. M. J. 2: 242, 1955.
   PubMedGoogle Scholar
• Badenoch, J.: The use of labelled vitamin B2 and gastric biopsy in the investigation of anaemia. Proc. Roy. Soc. Med. 47: 426–427, 1954.
   PubMedGoogle Scholar
• Loscalzo, A. E.: Treatment of epileptic patients with a combination of 3-methyl 5–5-phenylethylhydantoin and phenobarbital. J. Nerv. & Ment. Dis. 101: 537, 1945.
   Web of Science ®Google Scholar
• Mallach, J. F., Finkelman, I., Arieff, A. J. and Roberts, R. C.: Electrocardiographic changes resulting from Dilantin medication. Northwestern Univ. Bull., Med. School 17: 97, 1943.
   Google Scholar
• Williams, D.: Treatment of epilepsy with sodium diphenyl hydantoinate. Lancet 2: 678, 1939.
   Google Scholar
• Frankel, A. L. and Rothermich, N. O.: Polyarteritis nodosa: A review together with report of a case due to hydantoin sensitization. Ohio State M. J. 47: 1013, 1951.
   PubMedGoogle Scholar